Cognitive effects of pregabalin in the treatment of long-term benzodiazepine-use and dependence

Human Psychopharmacology

Volumn 29, Issue 3, 2014, Pages 224-229

  Oulis, Panagiotis ^a   Kalogerakou, Stamatina ^a   Anyfandi, Eleni ^a   Konstantakopoulos, George ^a,b   Papakosta, Vassiliki Maria ^a   Masdrakis, Vasilios ^a   Tsaltas, Eleftheria ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

benzodiazepine dependence; cognition; pregabalin

Indexed keywords

4 AMINOBUTYRIC ACID; BENZODIAZEPINE DERIVATIVE; CENTRAL NERVOUS SYSTEM AGENTS; PREGABALIN; PSYCHOTROPIC AGENT;

ANALOGS AND DERIVATIVES; CHEMICALLY INDUCED; COGNITION; COGNITION DISORDERS; DRUG EFFECTS; FEMALE; FOLLOW UP; HUMAN; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; SUBSTANCE-RELATED DISORDERS; TIME; TREATMENT OUTCOME;

BENZODIAZEPINES; CENTRAL NERVOUS SYSTEM AGENTS; COGNITION; COGNITION DISORDERS; FEMALE; FOLLOW-UP STUDIES; GAMMA-AMINOBUTYRIC ACID; HUMANS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHOTROPIC DRUGS; SUBSTANCE-RELATED DISORDERS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84898829231     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.2391     Document Type: Article

References (30)

1. American Psychiatric Association. 2000. Diagnostic and statistical manual of mental disorders, 4th edn Text revision. American Psychiatric Publishing, Inc.: Washington, DC.
2. Baldwin DS, Ajel K, Masdrakis VG, Nowak M, Rafiq R,. 2013. Pregabalin for the treatment of generalized anxiety disorder: an update. Neuropsychiatric Disease and Treatment 9: 883-892.
3. Bandelow B, Zohar J, Hollander E, Kasper S, Moeller HJ,. 2008. World Federation of Societies of Biological Psychiatry (WFSBP) task force on treatment guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders. World J Biol Psychiatry 9: 248-312.
4. Bandelow B, Sher L, Bunevicius R, et al,. 2012. World Federation of Societies of Biological Psychiatry task force on mental disorders in primary care. Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and post-traumatic stress disorder in primary care. Int J Psychiatry Clin Pract 16: 77-84.
5. Barker MJ, Greenwood KM, Jacson M, Crowe SF,. 2004a. Cognitive effects of long-term benzodiazepine use: a meta-analysis. CNS Drugs 18: 37-48.
6. Barker MJ, Greenwood KM, Jacson M, Crowe SF,. 2004b. Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis. Arch Clin Neuropsychol 19: 437-454.
7. Cambridge Cognition. 2006. CANTAB Eclipse Version 3: Test Administration Guide. Cambridge Cognition Ltd.: Cambridge, UK.
8. Chavant F, Favreliere S, Lafay-Chebassier C, Plazanet C, Perault-Pochat MC,. 2011. Memory disorders associated with consumption of drugs: updating through a case/noncase study in the French PharmacoVigilance Database. Br J Clin Pharmacol 72: 898-904.
9. Ciesielski AS, Samson S, Steinhoff BJ,. 2006. Neuropsychological and psychiatric impact of add-on titration of pregabalin versus levetiracetam: a comparative short-term study. Epilepsy Behav 9: 424-431.
10. Coull JT, Middleton HC, Robbins TW, Sahakian BJ,. 1995. Clonidine and diazepam have differential effects on tests of attention and learning. Psychopharmacology (Berl) 120: 322-332.
11. Deakin JB, Aitken MRF, Dowson JH, Robbins TW, Sahakian BJ,. 2004. Diazepam produces disinhibitory cognitive effects in male volunteers. Psychopharmacology (Berl) 173: 88-97.
12. Denis C, Fatseas M, Lavie E, et al,. 2006. Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings. Cochrane Database Syst Rev 3: CD005194.
13. Dooley DJ, Taylor CP, Donevan S, et al,. 2007. Ca2+ channel alpha2delta ligand: novel modulators of neurotransmission. Trends Pharmacol Sci 28: 75-82.
14. Downes JJ, Roberts AC, Sahakian BJ, Evenden JL, Morris RG, Robbins TW,. 1989. Impaired extradimensional shift performance in medicated and unmedicated Parkinson's disease: evidence for a specific attentional dysfunction. Neuropsychologia 27: 1329-1344.
15. First M, Spitzer R, Gibbon M, Williams J,. 1997. Structured Clinical Interview for DSM-IV Axis I Disorders, Research Version, Patient Edition. New York State Psychiatric Institute, Biometrics Research: New York.
16. Folstein MF, Folstein SE, McHugh PR,. 1975. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198.
17. Hadley SJ, Mandel FS, Schweizer E,. 2012. Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: a double-blind, placebo-controlled trial. J Psychopharmacol 26: 461-470.
18. Hindmarch I, Trick L, Ridout F,. 2005. A double-blind, placebo and positive-internal controlled (alprazolam) investigation of the cognitive and psychomotor profile of pregabalin in healthy volunteers. Psychopharmacology (Berl) 183: 133-143.
19. Kavoussi R,. 2006. Pregabalin: from molecule to medicine. Eur Neuropsychopharmacol 16 (Suppl 2): S128-133.
20. Oulis P, Konstantakopoulos G,. 2010. Pregabalin in the treatment of alcohol and benzodiazepine dependence. CNS Neurosci Ther 16: 45-50.
21. Oulis P, Konstantakopoulos G,. 2012. Efficacy and safety of pregabalin in the treatment of alcohol and benzodiazepine dependence. Expert Opin Investig Drugs 21: 1019-1029.
22. Oulis P, Κonstanntakopoulos G, Kouzoupis AV, et al,. 2008. Pregabalin in the discontinuation of long-term benzodiazepine use: a case-series. Hum Psychopharmacol 23: 337-340.
23. Owen AM, Downes JJ, Sahakian BJ, Polkey CE, Robbins TW,. 1990. Planning and spatial working memory following frontal lobe lesions in man. Neuropsychologia 28: 1021-1034.
24. Owen AM, Roberts AC, Polkey CE, Sahakian BJ, Robbins TW,. 1991. Extradimensional versus intradimensional set-shifting performance following frontal lobe excisions, temporal lobe excision or amygdalo-hippocampectomy in man. Neuropsychologia 29: 993-1006.
25. Owen AM, Sahakian BJ, Semple J, Polkey CE, Robbins TW,. 1995. Visuo-spatial short-term memory and learning after temporal lobe excision, frontal lobe excision, and amygdalo-hyppocampectomy in man. Neuropsychologia 33: 1-24.
26. Robbins TW, Semple J, Kumar R, et al,. 1997. Effects of scopolamine on delayed-matching-to-sample and paired associates tests of visual memory and learning in human subjects: comparison with diazepam and implications for dementia. Psychopharmacology (Berl) 134: 95-106.
27. Sahakian BJ, Morris RGM, Evenden JL, et al,. 1988. A comparative study of visuospatial memory and learning in Alzheimer type dementia and Parkinson's disease. Brain 111: 695-718.
28. Salinsky M, Storzbach D, Munoz S,. 2010. Cognitive effects of pregabalin in healthy volunteers: a double blind placebo-controlled trial. Neurology 74: 755-761.
29. Stewart SA,. 2005. The effects of benzodiazepines on cognition. J Clin Psychiatry 66 (Suppl 2): 9-13.
30. Swainson R, Hodges JR, Galton CJ, et al,. 2001. Early detection and differential diagnosis of Alzheimer's disease and depression with neuropsychological tasks. Dement Geriatr Cogn Disord 12: 265-280.